ArticleOncotarget2015

Discovery of a small molecule targeting SET-PP2A interaction to overcome BCR-ABLT315I mutation of chronic myeloid leukemia.

Shuzhen Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.